41.07 USD
-0.51 (-1.23%)
At close: Jan 30, 2026
40.79 USD
-0.28 (-0.68%)
After Hours: 1/30/2026, 4:30:32 PM
We assign a fundamental rating of 4 out of 10 to TWST. TWST was compared to 525 industry peers in the Biotechnology industry. TWST has a great financial health rating, but its profitability evaluates not so good. TWST is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- TWST had negative earnings in the past year.
- In the past year TWST has reported a negative cash flow from operations.
- TWST had negative earnings in each of the past 5 years.
- In the past 5 years TWST always reported negative operating cash flow.
1.2 Ratios
- The Return On Assets of TWST (-12.10%) is better than 82.48% of its industry peers.
- With an excellent Return On Equity value of -16.42%, TWST belongs to the best of the industry, outperforming 85.14% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.1% | ||
| ROE | -16.42% | ||
| ROIC | N/A |
ROA(3y)-24.14%
ROA(5y)-23.35%
ROE(3y)-31.13%
ROE(5y)-29.44%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- TWST's Gross Margin of 50.72% is fine compared to the rest of the industry. TWST outperforms 76.19% of its industry peers.
- In the last couple of years the Gross Margin of TWST has grown nicely.
- The Profit Margin and Operating Margin are not available for TWST so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 50.72% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.04%
GM growth 5Y9.75%
2. Health
2.1 Basic Checks
- TWST does not have a ROIC to compare to the WACC, probably because it is not profitable.
- TWST has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, TWST has more shares outstanding
- TWST has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- An Altman-Z score of 6.49 indicates that TWST is not in any danger for bankruptcy at the moment.
- TWST has a better Altman-Z score (6.49) than 76.00% of its industry peers.
- TWST has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 6.49 |
ROIC/WACCN/A
WACC8.88%
2.3 Liquidity
- A Current Ratio of 3.64 indicates that TWST has no problem at all paying its short term obligations.
- TWST has a Current ratio (3.64) which is in line with its industry peers.
- A Quick Ratio of 3.33 indicates that TWST has no problem at all paying its short term obligations.
- TWST has a Quick ratio of 3.33. This is comparable to the rest of the industry: TWST outperforms 42.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.64 | ||
| Quick Ratio | 3.33 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 41.39% over the past year.
- TWST shows a strong growth in Revenue. In the last year, the Revenue has grown by 20.32%.
- The Revenue has been growing by 33.11% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)41.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%23.73%
Revenue 1Y (TTM)20.32%
Revenue growth 3Y22.75%
Revenue growth 5Y33.11%
Sales Q2Q%16.88%
3.2 Future
- The Earnings Per Share is expected to grow by 18.82% on average over the next years. This is quite good.
- The Revenue is expected to grow by 15.84% on average over the next years. This is quite good.
EPS Next Y23.93%
EPS Next 2Y20.28%
EPS Next 3Y18.82%
EPS Next 5YN/A
Revenue Next Year15.05%
Revenue Next 2Y15.06%
Revenue Next 3Y15.45%
Revenue Next 5Y15.84%
3.3 Evolution
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- TWST reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year TWST is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- TWST's earnings are expected to grow with 18.82% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.28%
EPS Next 3Y18.82%
5. Dividend
5.1 Amount
- No dividends for TWST!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
TWIST BIOSCIENCE CORP / TWST FAQ
Can you provide the ChartMill fundamental rating for TWIST BIOSCIENCE CORP?
ChartMill assigns a fundamental rating of 4 / 10 to TWST.
What is the valuation status for TWST stock?
ChartMill assigns a valuation rating of 0 / 10 to TWIST BIOSCIENCE CORP (TWST). This can be considered as Overvalued.
How profitable is TWIST BIOSCIENCE CORP (TWST) stock?
TWIST BIOSCIENCE CORP (TWST) has a profitability rating of 3 / 10.
Can you provide the expected EPS growth for TWST stock?
The Earnings per Share (EPS) of TWIST BIOSCIENCE CORP (TWST) is expected to grow by 23.93% in the next year.